Immunoengineering: how nanotechnology can enhance cancer immunotherapy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 25860604.
- Also identified by DOI 10.1016/j.cell.2015.03.037.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Although cancer immunotherapy can lead to durable outcomes, the percentage of patients who respond to this disruptive approach remains modest to date. Encouragingly, nanotechnology can enhance the efficacy of immunostimulatory small molecules and biologics by altering their co-localization, biodistribution, and release kinetics.
Medical subject headings
- Cancer Vaccines
- Immunotherapy
- Nanotechnology
- Neoplasms